Main Article Content
Abstract
The study of quality of life (QOL) in medicine is a unique approach that allows you to fundamentally change the traditional view of the problem of health status and comprehensively study the indicators of human quality of life, evaluating all components of health – physical, psychological and social functioning. The study was conducted on the basis of the «Health Center for Children» (CH) of Barnaul, it includes 396 children. Of these, there were 169 (42.9 %) boys and 226 (57.1 %) girls. The average age of the examined children was 15.2 ± 2.3 years. Assessment of the quality of life of children with high thrombogenic risk factors and the comparison group showed that in the comparison group there were no statistically significant differences in the quality of life before the examination in the CH and 6 months after. And in the group of children with high thrombogenic risk factors, there was a significant improvement in the EF (emotional functioning ) (from 62 to 75 points) and LS (life at school) (from 61 to 74 points) (p < 0.05), while the PF (physical functioning) and SF (social functioning ) indicators did not statistically significantly change The most pronounced symptoms in all the children examined according to the MDASI questionnaire are pain, a feeling of sadness and weakness. These symptoms affected the mood of the children and their ability to enjoy life, as well as their general activity and attitude with other children.
Keywords
Article Details
Information about financing and conflict of interests
The authors declare that they have no apparent or potential conflicts of interest related to the publication of this article.
This work is licensed under a Creative Commons Attribution 4.0 License.
How to Cite
References
Novik AA, Ionova TI. A study of the quality of life in pediatrics: an educational method allowance. M.: RAEN, 2008. 104 p. Russian (Новик А.А., Ионова Т.И. Исследование качества жизни в педиатрии: уч.-метод. пособие. М.: РАЕН, 2008. 104 с.)
Baranov AA, Albitsky VYu, Vinyarskaya IV. The study of the quality of life in pediatrics. M.: Union of Pediatricians of Russia, 2010. 272 p. Russian (Баранов А.А., Альбицкий В.Ю., Винярская И.В. Изучение качества жизни в педиатрии. М.: Союз педиатров России, 2010. 272 с.)
Martynovich NN. Comprehensive assessment of children's health. Medical worker of a preschool educational institution. 2011; 1: 22. Russian (Мартынович Н.Н. Комплексная оценка состояния здоровья детей //Медработник дошкольного образовательного учреждения. 2011. № 1. С. 22)
Ursulenko EV. A modern view of thrombophilia. Siberian Medical Journal. 2010; 94(3): 127-129. Russian (Урсуленко Е.В. Современный взгляд на тромбофилию //Сибирский медицинский журнал. 2010. Т. 94, № 3. С. 127-129)
Shalnova SA, Kontsevaya AV, Karpov YuA et al. Epidemiological monitoring as a tool for planning prevention programs for CVD and their risk factors. Preventive medicine. 2012; 6: 23-26. Russian (Шальнова С.А., Концевая А.В., Карпов Ю.А. и др. Эпидемиологический мониторинг как инструмент планирования программ профилактики ХНИЗ и их факторов риска //Профилактическая медицина. 2012. № 6. С. 23-26)
Fetisov IN, Dobrolyubova AS, Lipin MA. Polymorphism of genes of folate metabolism and human disease. Bulletin of New Medical Technologies. 2007; X(1): 23-28. Russian (Фетисов И.Н., Добролюбова А.С., Липин М.А. Полиморфизм генов фолатного обмена и болезни человека //Вестник новых медицинских технологий. 2007. Т. X, № 1. С. 23-28)
Shcherbakova MYu, Startseva AI. Prevention of cardiovascular disease in children at high risk. Attending Doctor. 2003; 2: 13-15. Russian (Щербакова М.Ю., Старцева А.И. Профилактика сердечно-сосудистой патологии у детей группы высокого риска //Лечащий врач. 2003. № 2. С. 13-15)
Prevention of Cardiovascular Disease Pocket Guidelines for Assessment and Management of Cardiovascular Risk (WHO/ISH Cardiovascular Risk Prediction Charts for WHO epidemiological sub-regions AFR D and AFR E) Geneva, 2007. – [Электронный ресурс]. – Режим доступа: http://rpt.healthua. com/article/70.html
Muller T. Muchlack S. et al Methyl group-donating vitamins elevate 3-o-methyldopa in patients with Parkinson disease. Clin Neuropharmacol. 2013; 36(2): 52-54
Efimov ZS, Ozolinya LA. Hyperhomocysteinemia in clinical practice: a guide. M.: GEOTAR-Media, 2014. 55 p. Russian (Ефимов З.С., Озолиня Л.А. Гипергомоцистеинемия в клинической практике: руководство. М.: ГЭОТАР-Медиа, 2014. 55 с.)
Bertuccio P, Levi F, Lucchini F et al. Coronary heart disease and cerebrovascular disease mortality in young adults: recent trends in Europe. Eur J of Cardiovascular Prevention & Rehabilitation. 2011; 18: Р. 627-663
Buch AN, Coote JH, Townend JN. Mortality, cardiac vagal control and physical training – what’s the link? Exp. Physiol. 2002; 87(4): 423-435
Dionisio N, Jardin I. Homocysteine, intracellular signaling and thrombotic disorders. Curr. Med. Chem. 2010; 17(27): 3109-3119
Dubin R, Cushman M et al. Kidney function and multiple hemostatic markers: cross sectional associations in the multi-ethnic study of atherosclerosis. BMC Nephrol. 2011; 12(1): 3
Garcin JM, Cremades S, Garcia-Hejl C et al. Is hyperhomocysteinemia an additional risk factor of the metabolic syndrome? Metab. Syndr. Relat. Disord. 2006; 4(3): 185-195
